AbbVie

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade AbbVie 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ABBV

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. 

CEO
Robert A. Michael
CEORobert A. Michael
Employees
55,000
Employees55,000
Headquarters
North Chicago, Illinois
HeadquartersNorth Chicago, Illinois
Founded
2011
Founded2011
Employees
55,000
Employees55,000

ABBV Key Statistics

Market cap
400.98B
Market cap400.98B
Price-Earnings ratio
108.52
Price-Earnings ratio108.52
Dividend yield
2.84%
Dividend yield2.84%
Average volume
4.71M
Average volume4.71M
High today
$228.50
High today$228.50
Low today
$224.31
Low today$224.31
Open price
$227.13
Open price$227.13
Volume
2.15M
Volume2.15M
52 Week high
$244.81
52 Week high$244.81
52 Week low
$163.81
52 Week low$163.81

ABBV News

The Motley Fool 9h
Billionaire Israel "Izzy" Englander Has Loaded Up on This Dividend King. Should You?

Englander seems to have had several good reasons to aggressively buy shares of this big drugmaker. Some actions stand out more than others. Who takes the actio...

Billionaire Israel "Izzy" Englander Has Loaded Up on This Dividend King. Should You?
TipRanks 20h
AbbVie’s Latest Study on JUVÉDERM: What Investors Need to Know

Abbvie ((ABBV)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock po...

TipRanks 21h
AbbVie’s New Study on ELAPR002f Gel: A Potential Game-Changer for Acne Scars

Abbvie ((ABBV)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock po...

Analyst ratings

61%

of 31 ratings
Buy
61.3%
Hold
35.5%
Sell
3.2%

More ABBV News

TipRanks 22h
AbbVie’s New Phase 2 Study Targets MET Amplification in Solid Tumors

Abbvie ((ABBV)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powe...

TipRanks 23h
AbbVie’s Promising Study on ABBV-6628 for Geographic Atrophy: What Investors Need to Know

Abbvie ((ABBV)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock po...

TipRanks 1d
AbbVie’s Cariprazine Study: A New Chapter in Pediatric Treatment

Abbvie ((ABBV)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock po...

TipRanks 1d
AbbVie Withdraws Study on Hair Loss in Oriahnn Users: Market Implications

Abbvie ((ABBV)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powe...

Nasdaq 1d
Validea Detailed Fundamental Analysis - ABBV

Below is Validea's guru fundamental report for ABBVIE INC (ABBV). Of the 22 guru strategies we follow, ABBV rates highest using our P/B Growth Investor model ba...

Validea Detailed Fundamental Analysis - ABBV
The Motley Fool 2d
Prediction: These Dividend Stocks Could Outperform Growth Stocks in the Next Decade

Between growth and dividends, these companies have plenty to offer. Companies whose capital allocation plans prioritize dividends tend to have less money to re...

Prediction: These Dividend Stocks Could Outperform Growth Stocks in the Next Decade
TipRanks 4d
AbbVie Hold Rating: Balancing Strong Performance with Emerging Challenges

AbbVie, the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Asad Haider from Goldman Sachs maintained a Hold rating on the...

People also own

Based on the portfolios of people who own ABBV. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.